National Clinical Audit for Paediatric Diabetes
The overarching aim of the NPDA is the collection, analysis and effective reporting of robust comparative data on the quality of care and patient outcomes for young people being cared for in specialist paediatric diabetes units
United Kingdom-London: Miscellaneous health services
Section I: Contracting authority
I.1)Name, addresses and contact point(s)
Healthcare Quality Improvement Partnership
6th Floor, 45 Moorfields
For the attention of: Judith Hughes
EC2Y 9AE London
Telephone: +44 2079977311
General address of the contracting authority: http://www.hqip.org.uk/
Address of the buyer profile: http://www.hqip.org.uk/
Further information can be obtained from: HQIP
EC2Y 9AE London
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from:HQIP
EC2Y 9AE London
Tenders or requests to participate must be sent to: HQIP
EC2Y 9AE London
I.2)Type of the contracting authority
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: yes
Major Health Conditions Policy Team, Healthcare Policy Division, Directorate of Health, Policy, Department for Health and Social Services, Cathays Park
CF10 3NQ Cardiff
Section II: Object of the contract
II.1.1)Title attributed to the contract by the contracting authority:
II.1.2)Type of contract and location of works, place of delivery or of performance
Service category No 25: Health and social services
Main site or location of works, place of delivery or of performance: UK.
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
II.1.5)Short description of the contract or purchase(s)
To achieve, this national clinical audits must effectively deliver both quality assurance and quality improvement functions at local and national levels. Building on the achievements of the current audit, HQIP will now be recommissioning the NPDA to continue to support quality improvement and quality assurance in paediatric diabetes care.
The national diabetes audit (NDA) was established in 2004 as a combined adult and paediatric audit. It was developed as part of the Diabetes National Service Framework (NSF) implementation plan to drive service improvement and monitor the impact of the NSF. In 2011 the adult and paediatric components were tendered separately and the NPDA was thus established to measure outcomes and NICE recommended care processes received by children in Paediatric Diabetes Units (PDUs) in England and Wales. It has, since 2011, been delivered by the Royal College of Paediatric and Child Health and has achieved 100% participation from all 177 units in England and Wales.
This contract is being tendered under the Public Contracts Regulation 2015 under an open procurement procedure and has been advertised in accordance with EU requirements.
Aims of this National Clinical Audit are:
The overarching aim of the NPDA is the collection, analysis and effective reporting of robust comparative data on the quality of care and patient outcomes for young people being cared for in specialist paediatric diabetes units in England and Wales. The audit should at its core be a mechanism to drive improvement within the NHS for the benefit of patients and those working to deliver care. Engagement with clinicians, patients and commissioners (both local and national) and regional networks is therefore essential in order to support improvements.
This audit programme is expected to:
a. Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement;
b. Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate;
c. Enable Improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, commissioner, MDT,possibly consultant or clinical team level and other levels of reporting;
d. Engage patients, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit;
e. Consider the value and feasibility of linking data at an individual patient level to other relevant national data sets either from the outset or in the future, and plan for these linkages from the inception of the contract;
f. Ensure robust methodological and statistical input at all stages of the audit;
g. Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly;
h. Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data;
i. Utilise strong and effective project and programme management to deliver audit outputs on time and within budget;
j. Close engagement with the adult NDA and to seek opportunities to align scope, methodology and outputs to optimise a whole pathway analysis of diabetes care and outcomes from pregnancy and childhood through to adulthood; and
k. Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups in order to drive improvements in services for patients.
II.1.6)Common procurement vocabulary (CPV)
II.1.7)Information about Government Procurement Agreement (GPA)
II.1.9)Information about variants
II.2.1)Total quantity or scope:
II.2.2)Information about options
II.2.3)Information about renewals
Number of possible renewals: 2
II.3)Duration of the contract or time limit for completion
Section III: Legal, economic, financial and technical information
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
III.1.4)Other particular conditions
Description of particular conditions: As per acceptance of HQIP Standard Terms and Conditions of Contract as supplied with the ITT.
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
Minimum level(s) of standards possibly required: As detailed in the ITT.
As detailed in the ITT.
Minimum level(s) of standards possibly required:
As detailed in the ITT.
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service
Section IV: Procedure
IV.1.1)Type of procedure
IV.2.2)Information about electronic auction
IV.3.1)File reference number attributed by the contracting authority:
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening of tenders
Section VI: Complementary information
VI.1)Information about recurrence
VI.2)Information about European Union funds
This contract opportunity is being offered using e-procurement, please follow the attached link:
Suppliers will need to complete the Supplier Registration Form (SRF) within the e-procurement system, if a supplier has already been approved on the S2C E-Procurement portal they do not need to complete the SRF again.
VI.5)Date of dispatch of this notice: